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Abstract Synchrony provides a large number of cells at defined
points of the cell cycle. Highly synchronised cells are powerful
and effective tools for molecular analyses and for studying
the biochemical events of the cell cycle in plants. Usually, plant
cell suspensions can be synchronised by chemical agents, which
arrest the cell cycle by acting on the driving forces of the
cell cycle engine such as cyclin-dependent kinase activity,
enzymes involved in DNA synthesis or proteolysis of cell cycle
regulators or by acting on the cell cycle apparatus (mitotic
spindle). The specificity, reversibility and efficiency of each type
of cell cycle inhibitor are described and related to their mode of
action. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Plant development involves tight control and co-ordination
of proliferative activity and growth in meristematic and di¡er-
entiated tissues. To understand the regulation of plant
growth, it is necessary to identify regulators of plant cell di-
vision. Our knowledge of the molecular events of the cell cycle
has advanced considerably during the past few years through
exploitation of highly synchronised plant cell suspensions,
which provide a simple model to study proliferation in plants.
During the cell cycle, DNA replication is followed by the
equitable distribution of the genetic material to the daughter
cells. This process can be dissected into four steps: the S
phase, where DNA replication takes place, preceded by the
G1 phase and followed by the G2 phase and mitosis (M). A
synchronous cell culture is characterised by a high proportion
of cells proceeding to the same event of the cell cycle at the
same time. While natural synchrony is observed in certain
plant tissues which can be a source of synchronised cells,
induction of synchrony can be achieved by the arrest of a
cell population at a speci¢c stage by growth factor starvation
and/or addition of chemical agents. Chemical agents are most
frequently used to achieve simple and highly reproducible syn-
chrony of plant cells.
In this review, we discuss the most frequently used chemical
agents, their advantages and drawbacks as well as their mode
of action.
2. Synchronisation: general considerations
Chemical agents arrest the cell cycle by acting on the driv-
ing forces of the cell cycle engine (such as cyclin-dependent
kinase (CDK) activity, enzymes involved in DNA synthesis or
proteolysis of cell cycle regulators) or on the cell cycle appa-
ratus (mitotic spindle).
2.1. Speci¢city and reversibility
A chemical inhibitor used as a synchronising agent will
have special characteristics. The drug action has to be
phase-speci¢c and the chemical agent has to be e⁄cient at
low concentrations and rapidly e¡ective, to avoid abnormal-
ities in subsequent phases. To be sure that the cell division
arrest is not a result of cellular death, the block must be
reversed when the drug is removed.
2.2. Species speci¢city
The optimal concentration of a chemical inhibitor, the du-
ration of the treatment and time to re-enter the cell cycle have
to be calibrated for each plant species. The duration of the
treatment is dependent on generation time and the cell cycle
phase. For example, aphidicolin concentrations used to syn-
chronise cells at the G1/S border are 10-fold larger in Arabi-
dopsis cell suspensions [1] than in tobacco BY-2 cells [2] (Ta-
ble 2).
2.3. Cell suspension characteristics
The characteristics of the cell suspension also determine the
level of synchrony. This can be exempli¢ed by two commonly
used cell suspensions, tobacco BY-2 cells and Arabidopsis
thaliana cell cultures. Tobacco BY-2 cell suspensions are com-
posed of small clusters of cells with a relatively uniform cell
size, and approximately the same growth rate for the cell
population [2]. At stationary phase (7 days of culture), a ma-
jority of BY-2 cells have a 2C DNA content [3]. Since the cells
are in the same state, refreshing them with new medium and
applying a chemical treatment for 24 h is su⁄cient to block
the cell suspension homogeneously. In contrast, Arabidopsis
cell suspensions contain cells with a 2C and 4C DNA content
at stationary phase (unpublished data). This cell suspension is
formed of calli of di¡erent sizes and is composed of cell pop-
ulations growing at di¡erent rates. The block will occur in a
di¡erent way for each of these cell populations, and syn-
chrony will be low. The quality of the synchrony depends
on the features of the cell suspension. Therefore, a plant cell
suspension developed for synchronisation has to grow as fast
and homogeneously as possible.
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2.4. Synchrony procedure
The balance between toxicity and e⁄cacy prevents the use
of high concentrations of chemical inhibitors. Synchrony
gradually decreases from the moment the treatment is re-
leased. Therefore, a one-step treatment can be improved by
combining di¡erent inhibitors in a two-step blocking method.
The synchronised cells obtained after the ¢rst drug treatment
are further treated with a second drug to induce an arrest in
the subsequent phase. For example, after the release from a
one-step aphidicolin block, a mitotic index (MI) of about 30^
50% is obtained in tobacco BY-2 cells, whilst the MI is in-
creased up to 90% by a treatment with an anti-tubulin drug
after the release from an aphidicolin block [2,3].
3. Monitoring the synchrony of the cells
The proportion of synchronised cells is best estimated by
combining various methods since each technique facilitates
the monitoring of particular steps of the cell cycle.
3.1. Flow cytometric analysis
Flow cytometry is used to monitor G1, S and G2 phases of
the cell cycle. Flow cytometry allows rapid analysis of the
plant nuclear DNA content of large populations of cells and
is used to estimate the position of cells within the cell cycle
and their proportion with respect to the total cell population
[4]. However, in conventional univariate DNA-Hoechst £ow
cytometry, the G1 cells of the next cell cycle are indistinguish-
able from those of the original cell cycle. The discriminatory
multiparametric analysis of Hoechst 33258 versus propidium
iodide allows the detection of the cells that have progressed
from one cell cycle to the next after incorporation of the
thymidine analogue 5-bromodeoxyuridine (BrdU) [5]. This
method has been used to monitor cell cycle progression and
to distinguish cycling cells from resting cells in Arabidopsis cell
suspensions [6]. In other species, this technique was used to
study the induction or inhibition of DNA replication after
treatment by plant growth factors in Petunia hybrida meso-
phyll protoplasts [7] or after treatment by salicylic acid and
UV-light in tobacco BY-2 cell suspension [8]. The detection of
BrdU incorporation with an anti-BrdU antibody is an alter-
native quantitative methodology [9].
3.2. [3H]Thymidine labelling
This method is used to monitor DNA replication. After
subculture in the presence of [3H]thymidine nucleotides
([3H]TTP), cells incorporate [3H]TTP in the newly synthesised
DNA during replication. [3H] incorporation is estimated by
counting the radioactivity in a liquid scintillation counter [10].
The rate of [3H]thymidine incorporation is proportional to the
quantity of cells engaged in DNA synthesis. This method is
used in plant cell suspensions [11,12] and in plant tissues [13].
3.3. Cytology
Cytology is mainly used to determine the proportion of
cells in mitosis (MI), which is the number of mitotic ¢gures
related to the total number of cells. This number of dividing
cells is estimated by UV-light microscopy observations after
DNA staining with 4P,6-diamidino-2-phenylindole (DAP1) or
Hoechst 33342.
Microscopic analysis is complementary to £ow cytometry in
evaluating cells with 4C DNA content. This technique is par-
ticularly useful after an anti-tubulin drug treatment (colchi-
cine, oryzalin or propyzamide). Indeed, such drugs disorgan-
ise the mitotic spindle and scatter the chromosomes in the
cells. These metaphase-arrested cells cannot be counted by
£ow cytometry because the analysis of the DNA content re-
quires entire nuclei. In this case, coupling £ow cytometric
analysis with the determination of the percentage of mitotic-
like ¢gures will give the exact number of 4C cells [3,14].
3.4. Molecular markers
Expression of numerous cell cycle genes is cell cycle-reg-
ulated and occurs at di¡erent phases. The detection of
gene expression by Northern blots gives information about
the cell cycle stage. For example, in tobacco BY-2 cells,
CycD3 ;2 marks the entry of cells from G0 to G1 [15] and
histone H4 transcripts characterise the S phase [16]. The
mitotic cyclin genes can be used to monitor the G2 and
early M phases (for example, Nicta;CycB1 ;1 gene [3,17],
Arath;CycB1 ;1, [18]). The degree of synchrony may be
checked by combining markers of di¡erent cell cycle phases.
4. Main inhibitors used in plant cell cycle studies
The speci¢city of action of di¡erent chemical agents is pre-
sented in Table 1. References are listed in a chronological
order. Chemical agents and their speci¢c inhibitory actions
are illustrated during the cell cycle in Fig. 1.
4.1. Blocking at G1/S and G2/M transitions
CDKs play a central role in the initiation, ordering and
completion of cell cycle events (for review, see [27,28]). Inhib-
itors of CDK activity block the cell cycle and show anti-tu-
mour activities (for review, see [29]). A speci¢c inhibition of
human CDK activity was shown by a purine derivative, called
Table 1
Name Target/mechanism Block Reversibilitya References
HU ribonucleotide reductase G1/S progression +/3 [19]
Aphidicolin DNA polymerase K and N G1/S progression + [20]
Colchicine microtubule depolymerisation metaphase +/3 [21]
Oryzalin microtubule depolymerisation metaphase +/3 [22]
Propyzamide microtubule depolymerisation metaphase +/3 [23]
APM microtubule depolymerisation metaphase +/3 [24]
Mimosine ribonucleotide reductase G1, before initiation of replication +/3 [25]
Olomoucine CDK activity G1/S and G2/M + [6]
Roscovitine CDK activity G1/S and G2/M + [3]
MG132 proteasome metaphase/anaphase 3 [26]
a+ reversible arrest; 3 irreversible arrest; +/3 reversibility dependent on the duration of the treatment.
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olomoucine [30]. Two other purine derivatives, roscovitine
and bohemine, were shown to inhibit human CDK1 and
CDK2 activities at concentrations 10^100-fold less than olo-
moucine [31,32]. These purine derivatives were tested as po-
tential synchronising agents and used to characterise the re-
quirement of di¡erent CDK activities for cell cycle
progression in plants [3,6,7,33]). Their reversibility and specif-
icity make these inhibitors suitable for synchronisation.
In plant cells, olomoucine inhibits both the G1/S and the
G2/M transitions [6]. Roscovitine and bohemine provide more
speci¢c tools to investigate the functions of CDKs in plant
cells since roscovitine and bohemine are e⁄cient at a lower
concentration than olomoucine in mammals. The inhibitory
e¡ects of roscovitine act at two points in tobacco BY-2 cell
suspension: the G1/S and G2/M transitions [3]. In Arabidopsis
cell suspensions, 50 WM of roscovitine is needed to block the
cell cycle in G1. This arrest is reversible (unpublished data).
Roscovitine and bohemine were used on Vicia faba root tip
cells and were shown to disturb the spindle formation when
applied to metaphase cells [33].
4.2. DNA synthesis inhibitors
DNA replication depends on the synthesis of deoxyribonu-
cleotides and the activity of the enzymes of the replication
machinery. Di¡erent DNA synthesis inhibitors are e⁄cient
in plants: hydroxyurea (HU), mimosine and aphidicolin.
HU inhibits the activity of ribonucleotide diphosphate
reductase, thus depriving the cells of newly synthesised de-
oxyribonucleotide triphosphates, consequently preventing
DNA replication [19]. In mammal cells, HU does not lead
to synchrony at the G1/S boundary at low concentrations
whereas, at high concentrations, HU is toxic to S phase cells
[34].
HU treatment is more e⁄cient when applied to protoplasts
than to entire plants. The cell wall, the diversity of cell-types
and uptake of the drug by the root system are physical bar-
riers for entry of the chemical agent. The quantity of inhibitor
required to block activity in whole plant organs is often 10-
fold higher than that required for plant cells in suspension
culture. For instance, 5 mM HU is needed to synchronise
alfalfa cell suspensions in S phase [35] whereas 100 mM HU
Table 2
DNA synthesis inhibitors
Aphidicolin HU Mimosine
Tobacco BY-2 Nicotiana
tabacum
6 Wg/ml for 24 h [2]; 20 Wg/ml
for 24 h [12]
from 30 to 60 mM for 24 h [12] 2 mM for 24 h [41]
A. thaliana cell suspension from 20 to 50 Wg/ml [44]; 30 WM
or 10 Wg/ml for 20 h [6]
100 WM for 28 h
(irreversible arrest) [53]
Medicago sativa 10 or 20 Wg/ml for 36 h [52] 5 mM for 24^36 h [35]
Catharanthus roseus 50 WM or 17 Wg/ml [11]
A. thaliana roots 100 mM for 48 h [36]; 2^100 mM
for 48 h [13]
P. hybrida mesophyll protoplasts 200 WM for 24 h [25]
Pisum sativum roots 150 WM or 50 Wg/ml for 15 h [54]
V. faba roots 2.5 mM for 18 h [14]
Fig. 1. Chemical agents arrest the cell cycle progression at di¡erent points.
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is needed for Arabidopsis roots [13,36] (Table 2). Moreover,
the release from HU allows the synchronisation at subsequent
phases. Eight hours after the release from a HU block, 55% of
mitotic synchrony can be observed in root tips of V. faba [14].
Mimosine, a plant amino acid, is extracted from koa hoale
seeds (Acacia koa). This inhibitor blocks cell cycle progression
at the G1/S interface but the precise mechanism of mimosine
action is still unknown. In mammals, some clues are emerging
on mimosine action. It was ¢rst described as a suppressor in
the formation of the rare amino acid, hypusine, in the eukary-
otic translation factor 4D [37]. According to [38], the mimo-
sine block occurs before the establishment of active DNA
replication forks by altering deoxyribonucleotide metabolism.
This inhibitor can be used in the analysis of initiation of DNA
replication in mammals [39].
In the light of its e¡ect in mammals, mimosine was tested
on the plant cell cycle. Nuclei of P. hybrida mesophyll proto-
plasts predominantly have a 2C DNA content and can be
induced to re-enter the cell cycle [40]. Mimosine is able to
block P. hybrida mesophyll protoplasts in G1 [25]. Very low
DNA synthesis and histone H3 gene transcription were de-
tected when a concentration of 2 mM of mimosine was ap-
plied for 24 h to tobacco BY-2 cells [41] (Table 2). Hence,
mimosine blocks BY-2 cells before S phase entry.
Aphidicolin is a widely used inhibitor for blocking replica-
tion. Aphidicolin is extracted from the fungus Cephalosporium
aphidicolia and is a speci¢c DNA polymerase K and N inhib-
itor that blocks reversibly the replication machinery [42].
After the release from aphidicolin, the block is rapidly rever-
sible because DNA polymerase K is immediately available and
active to continue DNA replication. This rapid reversibility is
an advantage when compared to the e¡ects of HU and mim-
osine, where de novo synthesis of deoxyribonucleotide tri-
phosphates is required before replication can start. Since the
initiation of replication is not blocked by aphidicolin, this
inhibitor is only used to study progression from the S phase.
A G1/S block is observed with 20 Wg/ml of aphidicolin in
tobacco BY-2 cell suspensions, whereas an enrichment in
S phase cells (up to 80%) is obtained with a lower concentra-
tion, 4 Wg/ml [3] (Table 2). Histone H4 gene is expressed in
parallel with DNA synthesis with a low concentration aphidi-
colin treatment (3 Wg/ml) in tobacco BY-2 cell suspensions
[12]. This suggests that aphidicolin acts by slowing down rep-
lication. An aphidicolin treatment can induce inhibition of
DNA repair in mammals [43], but the expression of a DNA
repair gene (AtRAD51) is not induced by aphidicolin itself in
Arabidopsis [1]. Aphidicolin has been used to study S phase-
speci¢c gene expression of histone genes [12,44,45], a prolifer-
ating cellular nuclear antigen gene [46] and the AtRAD51 gene
[1].
A large number of cells going through the M phase can be
obtained from a cell population released from a G1/S arrest,
as described previously with HU. The release from the aphi-
dicolin block allows the study of genes expressed at the sub-
sequent G2/M transition, like cyclin genes [17,18,47^50].
Moreover, cdc2 gene expression and measurement of CDK
activities during the cell cycle was made possible by using
aphidicolin and the subsequent release of the arrested cells
[3,51,52].
These chemical agents e⁄ciently deliver a G1/S block and
after the progression of cells to mitosis, the release from this
block can be studied.
4.3. Blocking at mitosis
4.3.1. Anti-tubulin drugs. At the onset of mitosis, the mi-
crotubule network is essential for spindle organisation and
chromosome movement. Microtubules are dynamic polymers
composed of tubulin. Inhibition of microtubule polymerisa-
tion is one of the key actions of anti-mitotic drugs, which
act at the metaphase/anaphase transition. The anti-tubulin
drugs were widely used in studies of microtubule and micro-
¢lament dynamics [55]. A metaphase arrest can be obtained
by the use of anti-tubulin drugs, like colchicine, oryzalin, pro-
pyzamide and amiprosphos-methyl (APM) [24] (for review,
see [56]). Large quantities of plant chromosomes are obtained
by the use of cell cultures that are synchronised at mitosis
with chemical agents that disturb microtubule polymerisation
[57].
To obtain higher synchrony, the cells are usually ¢rst
synchronised with aphidicolin, washed and further treated
with the mitotic agent [2]. Ninety percent of tobacco BY-2
cells are blocked at metaphase when treated with propyzamide
or oryzalin [2,3] (Table 3). The mitotic agents do not block
cells inde¢nitely in metaphase, since, after a few hours, the
chromosomes decondense and form micronuclei [24].
Colchicine is an alkaloid extracted from Colchicum autum-
nale that binds to tubulin dimers and prevents the formation
of the mitotic spindle. Colchicine has been shown to bind with
high a⁄nity in mammalian cells, and induces metaphase ar-
rest at concentrations of 1037 M (for review, see [58]). This
agent is e¡ective at millimolar levels in plants ([21]). However,
mitotic arrest of plant cells is preferably obtained with drugs
having the same e¡ect but at micromolar concentrations such
as oryzalin, APM and propyzamide. The use of lower concen-
trations of inhibitor, which are easier to wash out, can avoid
abnormal mitosis and micronuclei formation.
Oryzalin is a dinitroaniline herbicide that has strong bind-
ing a⁄nity for plant tubulins and inhibits microtubule poly-
merisation [22]. This drug was shown to arrest cells at meta-
phase [24] (Table 3). Oryzalin was also used at low
concentrations (from 0.17 WM to 1 WM) to study microtubule
organisation in Arabidopsis roots [59]. APM is a phosphoric
amide that has a high microtubule depolymerising activity
[24]. Prolonged APM treatments can induce micronucleation
in plant cells [60]. Propyzamide is a herbicide that induces
mitotic arrest [23]. Cells blocked for 13 h with propyzamide
Table 3
Anti-tubulin drugs
Oryzalin Propyzamide
Tobacco BY-2 15 WM for 24 h [18] 1.6 Wg/ml or 6 WM for 4 h from cells released for 6 h from an aphidicolin block [2] ;
3 WM for 10^14 h [3]
P. hybrida mesophyll
protoplasts
3 WM for 14 h [6]
A. thaliana roots 2^30 WM for 48 h [13]
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or oryzalin after an aphidicolin block contain individual meta-
phase chromosomes [3] (Table 3). The crucial point with these
drugs is that the treatment has to be short (less than 14 h),
otherwise it leads to abnormal cell division ¢gures and micro-
nuclei formation (unpublished data).
4.3.2. Proteasome inhibitors. The events at late mitosis,
from sister chromatid separation to cytokinesis, are governed
by ubiquitin-dependent proteolysis of key regulatory proteins.
A major step in this proteolysis is catalysed by a multimeric
ubiquitin ligase known as the anaphase-promoting complex
(APC). This complex targets B-type cyclins and other regula-
tory proteins for degradation to the 26S proteasome, allowing
exit from mitosis [61]. Proteasome inhibition blocks APC ac-
tion, preventing the destruction of cyclins and consequently
escape from mitosis (for review, see [62]). MG132 is a peptide
aldehyde (carboxybenzoxyl-leucinyl-leucinyl-leucinal) that
functions as a substrate analogue and inhibits the 26S protea-
some activity. MG132 was shown to arrest tobacco BY-2 cells
at metaphase/anaphase transition [26]. Following a release
from aphidicolin, a MG132 treatment leads to 50% metaphase
cells [26]. However, the treatment is not completely reversible
since aberrant anaphase ¢gures are observed after the release
from the MG132. Lactacystin is a more speci¢c but very ex-
pensive APC inhibitor and could be particularly useful for
investigations of the requirement for the APC at the meta-
phase to anaphase transition [62].
5. Conclusion
Several chemical agents are at present available to syn-
chronise plant cells for experiments on plant cell cycle pro-
gression. The active search for chemical inhibitors of CDK
activity is stimulated by their potential therapeutic applica-
tions in cancer treatment. The crystallisation of CDK^inhib-
itor complexes greatly improved knowledge about the shape
complementarity between an inhibitor and its target enzyme.
Structural data from active CDK^cyclin inhibitor complexes
revealed novel inhibitory interactions (for review, see [29]).
This research provides new tools to study the function of
CDK in plants. The phase in which cells are arrested by these
inhibitors is an indication of the function(s) of these key reg-
ulators in the cell cycle progression. In return, the highly
synchronised suspensions obtained with this type of inhibitor
can be used to study the expression of cell cycle-regulated
functions. The pieces of the puzzle of plant cell cycle events
begin to fall into place by the integration of various results
obtained with highly synchronised cell suspensions [28].
Acknowledgements: We are extremely grateful to Dr James Dat for
his useful suggestions after reading the manuscript. We would like to
thank Franc°oise Bernardi and Christophe Tre¤hin for advice on the
manuscript. S.P. was supported by an EC Grant number ERBFM-
BIT961724.
References
[1] Doutriaux, M.-P., Couteau, F., Bergounioux, C. and White, C.
(1998) Mol. Gen. Genet. 257, 283^291.
[2] Nagata, T., Nemoto, Y. and Hasezawa, S. (1992) Int. Rev. Cytol.
132, 1^30.
[3] Planchais, S., Glab, N., Tre¤hin, C., Perennes, C., Bureau, J.-M.,
Meijer, L. and Bergounioux, C. (1997) Plant J. 12, 191^202.
[4] Galbraith, D.W. (1990) in: Methods in Cell Biology (Darzynkie-
wicz, Z. and Grissman, H.A., Eds.), Vol. 33, pp. 549^562, Aca-
demic Press, San Diego, CA.
[5] Ormerod, M.G. and Kubbies, M. (1992) Cytometry 13, 678^685.
[6] Glab, N., Labidi, B., Qin, L.-X., Tre¤hin, C., Bergounioux, C. and
Meijer, L. (1994) FEBS Lett. 353, 207^211.
[7] Tre¤hin, C., Planchais, S., Glab, N., Perennes, C., Tregear, J. and
Bergounioux, C. (1998) Planta 206, 215^224.
[8] Perennes, C., Glab, N., Guglieni, B., Doutriaux, M.-P., Phan,
T.H., Planchais, S. and Bergounioux, C. (1999) J. Cell Sci. 112,
1181^1190.
[9] Gratzner, H.G. (1982) Science 218, 474^475.
[10] Komada, H. and Komamine, A. (1995) in: Methods in Cell
Biology (Galbraith, D.W., Bourque, D.P. and Bohnert, H.J.,
Eds.), Vol. 49, pp. 315^329, Academic Press, New York.
[11] Ito, M., Kodama, H. and Komamine, A. (1991) Plant J. 1, 141^
148.
[12] Reichheld, J.-P., Sonobe, S., Cle¤ment, B., Chaubet, N. and Gi-
got, C. (1995) Plant J. 7, 245^252.
[13] De Almeida Engler, J., De Vleesschauwer, V., Bu«rssens, S., Ce-
lenza, J.L., Inze¤, D., Van Montagu, M., Engler, G. and Gheysen,
G. (1999) Plant Cell 11, 793^807.
[14] Lucretti, S. and Dolezel, J. (1995) in: Methods in Cell Biology
(Galbraith, D.W., Bourque, D.P. and Bohnert, H.J., Eds.), Vol.
50, pp. 61^83, Academic Press, New York.
[15] Sorell, D.A., Combettes, B., Chaubet-Gigot, N., Gigot, C. and
Murray, J.A.H. (1999) Plant Physiol. 119, 343^351.
[16] Chaboute¤, M.-E., Chaubet, N., Phillips, G., Ehling, M. and Gi-
got, C. (1987) Plant Mol. Biol. 8, 179^191.
[17] Qin, L.X., Perennes, C., Richard, L., Bouvier-Durand, M., Tre¤-
hin, C., Inze¤, D. and Bergounioux, C. (1996) Plant Mol. Biol. 32,
1093^1101.
[18] Shaul, O., Mironov, V., Bu«rssens, S., Van Montagu, M. and
Inze¤, D. (1996) Proc. Natl. Acad. Sci. USA 14, 4868^4872.
[19] Young, C.W. and Hodas, S. (1964) Science 146, 1172^1174.
[20] Ikegami, S., Taguchi, T., Ohashi, M., Oguro, M., Nagano, H.
and Mano, Y. (1978) Nature 275, 458^460.
[21] Morejohn, L.C., Bureau, C.E., Tocchi, L.P. and Fosket, D.E.
(1984) Proc. Natl. Acad. Sci. USA 81, 1440^1444.
[22] Morejohn, L.C., Bureau, T.E., Mole¤-Bajer, J., Bajer, A.S. and
Fosket, D.E. (1987) Planta 172, 252^264.
[23] Akashi, T., Izumi, K., Nagano, E., Enomoto, M., Mizuno, K.
and Shibaoka, H. (1988) Plant Cell Physiol. 29, 1053^1062.
[24] Verhoeven, H.A., Sree Ramulu, K. and Dijkhuis, P. (1990) Plan-
ta 182, 408^414.
[25] Perennes, C., Qin, L.-X., Glab, N. and Bergounioux, C. (1993)
FEBS Lett. 333, 141^145.
[26] Genschik, P., Criqui, M.-C., Parmentier, Y., Derevier, A. and
Fleck, J. (1998) Plant Cell 10, 2063^2075.
[27] Nigg, E.A. (1995) Bioessays 17, 471^480.
[28] Mironov, V., De Veylder, L., Van Montagu, M. and Inze¤, D.
(1999) Plant Cell 11, 509^522.
[29] Meijer, L. (1996) Trends Cell Biol. 6, 393^397.
[30] Vesely, J., Havlicek, L. and Strnad, M. (1994) Eur. J. Biochem.
224, 771^786.
[31] De Azevedo, W.F., Leclerc, S., Meijer, L., Havlicek, L., Strnad,
M. and Kim, S.-H. (1997) Eur. J. Biochem. 243, 518^526.
[32] Havlicek, L., Hanus, J., Vesely, J., Leclerc, S., Meijer, L., Shaw,
G. and Strnad, M. (1997) J. Med. Chem. 40, 408^412.
[33] Biranova, P., Dolezel, J., Draber, P., Heberle-Bors, E., Strnad,
M. and Bo«gre, L. (1998) Plant J. 16, 697^707.
[34] Pedrali-Noy, G., Spadari, S., Miller-Faure's, A., Miller, A.O.A.,
Kruppa, J. and Koch, G. (1980) Nucleic Acids Res. 8, 377^397.
[35] Magyar, Z., Bako, L., Bo«gre, L., Dedeoglu, D., Kapros, T. and
Dudits, D. (1993) Plant J. 4, 151^161.
[36] Ferreira, P., Hemerly, A., de Almeida Engler, J., Bergounioux,
C., Bu«rssens, S., Van Montagu, M., Engler, G. and Inze¤, D.
(1994) Proc. Natl. Acad. Sci. USA 91, 11313^11317.
[37] Ho¡man, B.D., Hanauske-Abel, H.M., Flint, A. and Lalande,
M. (1991) Cytometry 12, 26^32.
[38] Gilbert, D.M., Neilson, A., Miyazawa, H., DePamphilis, M.L.
and Burhans, W.C. (1995) J. Biol. Chem. 270, 9597^9606.
[39] Krude, T. (1999) Exp. Cell Res. 247, 148^159.
[40] Bergounioux, C., Perennes, C., Hemerly, A., Qin, X.-L., Sarda,
C., Inze¤, D. and Gadal, P. (1992) Plant Mol. Biol. 20, 1121^1130.
FEBS 23799 22-6-00
S. Planchais et al./FEBS Letters 476 (2000) 78^8382
[41] Reichheld, J.-P., Gigot, C. and Chaubet-Gigot, N. (1998) Nucleic
Acids Res. 26, 3255^3262.
[42] Sala, F., Parisi, B., Burroni, D., Amileni, A.R., Pedrali-Noy, G.
and Spadari, S. (1980) FEBS Lett. 117, 93^98.
[43] Barret, J.M., Salles, B., Provot, C. and Hill, B.T. (1997) Carcino-
genesis 18, 2441^2445.
[44] Callard, D. and Mazzolini, L. (1997) Plant Physiol. 115, 1385^
1395.
[45] Ohtsubo, N., Nakayama, T., Kaya, H., Terada, R., Shimamoto,
K., Meshi, T. and Iwabuchi, M. (1997) Plant J. 11, 1219^1225.
[46] Komada, H., Ito, M., Ohnishi, N., Suzuka, I. and Komamine, A.
(1991) Eur. J. Biochem. 197, 495^503.
[47] Komada, H., Ito, M. and Komamine, A. (1994) Plant Cell Phys-
iol. 35, 529^537.
[48] Setiady, Y.Y., Sekine, M., Hariguchi, N., Yamamoto, T., Kou-
chi, H. and Shinmyo, A. (1995) Plant J. 8, 949^957.
[49] Reichheld, J.-P., Chaubet, N., Shen, W.H., Renaudin, J.-P and
Gigot, C. (1996) Proc. Natl. Acad. Sci. USA 93, 13819^13824.
[50] Ito, M., Criqui, M.C., Sakabe, M., Ohno, T., Hata, S., Kouchi,
H., Hashimoto, J., Fukuda, H., Komamine, A. and Wanatabe,
A. (1997) Plant J. 11, 983^992.
[51] Setiady, Y.Y., Sekine, M., Hariguchi, N., Kouchi, H. and Shin-
myo, A. (1996) Plant Cell Physiol. 37, 369^376.
[52] Magyar, Z., Meszaros, T., Miskolczi, P., Deal, M., Feher, A.,
Brown, S., Kondorosi, E., Athanasiadis, A., Pongor, S., Bilgin,
M., Bako, L., Koncz, C. and Dudits, D. (1997) Plant Cell 9, 223^
235.
[53] Fuerst, R.A., Soni, R., Murray, J.A.H. and Lindsey, K. (1996)
Plant Physiol. 112, 1023^1033.
[54] Sgorbati, S., Sparvoli, E., Levi, M., Galli, M.G., Citterio, S. and
Chiatante, D. (1991) Physiol. Plant 81, 507^512.
[55] Schmit, A.C. and Lambert, A.-M. (1988) Biol. Cell 64, 309^319.
[56] Morejohn, L.C. and Fosket, D.E. (1991) Pharmacol. Ther. 51,
217^230.
[57] Conia, J., Bergounioux, C., Perennes, C., Mu«ller, P., Brown, S.
and Gadal, P. (1987) Cytometry 8, 500^508.
[58] Jordan, M.A. and Wilson, L. (1999) in: Methods in Cell Biology
(Rieder, C.L., Ed.), Vol. 61, pp. 267^295, Academic Press, New
York.
[59] Baskin, T.I., Wilson, J.E., Cork, A. and Williamson, R.E. (1994)
Plant Cell Physiol. 35, 935^942.
[60] Sree Ramulu, K., Verhoeven, H.A., Djkuis, P. and Gilissen,
L.J.W. (1990) Plant Sci. 69, 123^133.
[61] Murray, A. (1995) Cell 81, 149^152.
[62] Lee, D.H. and Goldberg, A.L. (1998) Trends Cell Biol. 8, 397^
403.
FEBS 23799 22-6-00
S. Planchais et al./FEBS Letters 476 (2000) 78^83 83
